Malaria in East Africa by Watkins, WM, Marsh, K

The evolution of drug-resistant malaria: the role of drug elimination half-life. by Hastings, I, Watkins, WM, White, N

Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy. by Watkins, WM, Woodrow, C, Marsh, K

Genetics of the cell surface by Bodmer, W, Watkins, WM, Stocker, B

Antimalarial dosing regimens and drug resistance. by Barnes, K, Watkins, WM, White, N

Pharmacology of absorption and distribution: optimal use of antimalarial drugs in the treatment of severe falciparum malaria in Kenya. by Watkins, WM, Winstanley, P, Marsh, K

Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya. by Haruki, K, Winstanley, P, Watkins, WM, Marsh, K

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006. by Certain, L, Briceño, M, Kiara, S, Nzila, A, Watkins, WM, Sibley, C

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. by Barnes, K, Little, F, Smith, P, Evans, A, Watkins, WM, White, N

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. by Wilairatana, P, Kyle, D, Looareesuwan, S, Chinwongprom, K, Amradee, S, White, N, Watkins, WM

Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. by Winstanley, P, Mberu, E, Watkins, WM, Murphy, SA, Lowe, B, Marsh, K

Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine. by Murphy, S, Watkins, WM, Bray, P, Lowe, B, Winstanley, P, Peshu, N, Marsh, K

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). by Lourens, C, Watkins, WM, Barnes, K, Sibley, C, Guerin, P, White, N, Lindegardh, N

Changing home treatment of childhood fevers by training shop keepers in rural Kenya. by Marsh, V, Mutemi, WM, Muturi, J, Haaland, A, Watkins, WM, Otieno, G, Marsh, K

Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus. by Ogutu, B, Newton, C, Muchohi, SN, Otieno, G, Edwards, G, Watkins, WM, Kokwaro, G

Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. by Pasvol, G, Newton, C, Winstanley, P, Watkins, WM, Peshu, N, Were, J, Marsh, K, Warrell, D

A single dose of intramuscular sulfadoxine-pyrimethamine as an adjunct to quinine in the treatment of severe malaria: pharmacokinetics and efficacy. by Newton, C, Winstanley, P, Watkins, WM, Mwangi, I, Waruiru, C, Mberu, E, Warn, P, Nevill, C, Marsh, K

Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria. by Watkins, WM, Winstanley, P, Mberu, E, Kokwaro, G, Murphy, SA, Newton, C, Mwangi, I, Forster, D, Marsh, K

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. by Sulo, J, Chimpeni, P, Hatcher, J, Kublin, J, Plowe, C, Molyneux, M, Marsh, K, Taylor, T, Watkins, WM, Winstanley, P

Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. by Gilks, C, Brindle, R, Otieno, L, Bhatt, S, Newnham, R, Simani, P, Lule, G, Okelo, G, Watkins, WM, Waiyaki, P